ESTRO 36 Programme book and exhibition guide

S. Ruiz Arrebola (Spain), A.M. Tornero-López, J.M. De la Vega, P.J. Prada, D. Guirado

EP-1768

ELECTRONIC POSTERS

> Hypofractionated EBRT and single fraction HDR brachytherapy for patients with prostate cancer. D.E. Kazberuk (Poland), T.M. Filipowski, A. Szmigiel-Trzcińska, M. Niksa, D. Hempel, J. Topczewska-Bruns, W. Nowik, B. Pancewicz-Janczuk > Unpredictable PSA failure in intermediate-risk prostate cancer after seed implant brachytherapy K. Kikuchi (Japan), R. Nakamura, H. Kakuhara, S. Yamaguchi, H. Oikawa, W. Obara, H. Ariga > Low dose rate brachytherapy for prostate cancer: A Brazilian Institution experience. E.T.T. Leite (Brazil), J.L.F.D. Silva, E. Capelletti, G.N. Marta > HDR Brachytherapy in the treatment of prostate cancer – the Vienna Experience O. Komina (Austria), C. Seitz-Kästner, J. Hofbauer, M. Kuntner, J. Wimmer, T. Knocke-Abulesz, E. Nechvile > Clinical outcomes in localised prostate cancer treated with HDR Brachytherapy as single fraction L. Larrea (Spain), E. López-Muñoz, P. Antonini, V. Gonázlez, M.C. Baños, J. Bea, M.A. García > Randomized phase II trial of IGRT with or without HDR boost in intermediate-risk prostate cancer E. Vigneault (Canada), G. Morton, W. Perulekar, T. Niazi, G. Springer, M. Barkati, P. Chung, W. Koll, A. Kamran, M. Montreal, K. Ding, A. Loblaw > Acute toxicity in early cancer prostate patients: low dose rate vs high dose rate monotherapy S. Rodríguez Villalba (Spain), A. Otal Palacín, J. Richart Sanchez, J. Pérez-Calatayud, M. Santos Ortega

EP-1769

EP-1770

EP-1771

EP-1772

EP-1773

EP-1774

EP-1775

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

306